There were 318 press releases posted in the last 24 hours and 358,012 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Intercept Announces Efficacy and Safety Data from Phase 3 REGENERATE Study in Liver Fibrosis due to NASH to be Presented at NASH-TAG Conference 2023

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image